Nicola Bridges

Chelsea and Westminster Hospital NHS Foundation Trust — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index1.5kcitations85works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Syndromes and Imprinting(20), Growth Hormone and Insulin-like Growth Factors(12), Diabetes Management and Research(11), Cystic Fibrosis Research Advances(10), Genetics and Neurodevelopmental Disorders(8)

Publications85 total

Diazoxide Choline Extended-release Tablets in Prader-Willi Syndrome: A Randomized, Double-blind, Withdrawal Period Study
The Journal of Clinical Endocrinology & Metabolism·2025· 1 citedOpen Access
Authors Should Label Their Own Documents
arXiv (Cornell University)·2025Open Access
Disorders of growth
Medicine·2025
7519 Withdrawal of DCCR (Diazoxide Choline) Extended-Release Tablets Worsens Hyperphagia and Increases Weight and BMI in a 16-week Double-blind, Placebo-controlled, Randomized Withdrawal Period in Patients with Prader Willi Syndrome
Journal of the Endocrine Society·2024· 1 citedOpen Access
Prader–Willi syndrome: guidance for children and transition into adulthood
Endocrine Connections·2024· 9 citedOpen Access
Diazoxide choline extended‐release tablet in people with <scp>Prader‐Willi</scp> syndrome: results from long‐term open‐label study
Obesity·2023· 13 citedOpen Access
Growth reference charts for children with hypochondroplasia
American Journal of Medical Genetics Part A·2023· 12 citedOpen Access
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial
The Journal of Clinical Endocrinology & Metabolism·2023· 41 citedOpen Access
Long-term safety of diazoxide choline extended-release (DCCR) tablets in patients with prader-willi syndrome
Endocrine Abstracts·2022
Comparison of hyperphagia and problem behaviors in participants with prader-willi syndrome (PWS) receiving diazoxide choline extended-release (DCCR) with matched participants in PATH for PWS (PfPWS)
Endocrine Abstracts·2022
Disorders of growth
Medicine·2021
The impact of COVID-19 lockdown on glycaemic control and BMI in children with type 1 diabetes mellitus (T1DM)
59th ESPE Annual Meeting (ESPE 2021 Online)·2021
How do I differentiate hypog hypog from constitutional delay?
Endocrine Abstracts·2018
Use of recombinant human growth hormone in a neonate with Prader Willi Syndrome to improve respiratory status
Endocrine Abstracts·2018
Hypoventilation disproportionate to OSAS severity in children with Prader-Willi syndrome
Archives of Disease in Childhood·2018· 27 cited
Unique challenges of cystic fibrosis‐related diabetes
Diabetic Medicine·2018· 38 citedOpen Access
Quantifying fluctuation in glucose levels to identify early changes in glucose homeostasis in cystic fibrosis
Journal of Cystic Fibrosis·2018· 17 citedOpen Access
Clinical implications of changes to fluid therapy in 2015 BSPED DKA guideline - a comparative audit, pre and post guideline implementation.
Endocrine Abstracts·2017
Disorders of growth
Medicine·2017· 2 cited
290 The utility of serial continuous glucose monitoring for diagnosis of CF-related diabetes in children
Journal of Cystic Fibrosis·2017Open Access
page 1 of 5Next →

Frequent Co-authors

C G D Brook(8), Peter C. Hindmarsh(8), Evelien Gevers(5), Neil Cowen(5), Peter C. Hindmarsh(4), C. G. D. Brook(4), Anthony P. Goldstone(4), J.C. Burgess(4), Kathryn Obrynba(4), Eric I. Felner(4), Lynne M. Bird(4), Melissa Lah(4), Elizabeth Littlejohn(4), Alex Cooke(3), Diana Bilton(3), Nicholas J. Simmonds(3), Jennifer Miller(3), Jack A. Yanovski(3), Parisa Salehi(3), Ashley H. Shoemaker(3)